Treating kratom withdrawal with clonidine or buprenorphine
Part of Mental health clinical trials.
This trial studies medicines (clonidine and/or buprenorphine) to help manage kratom dependence and kratom withdrawal symptoms. You may be asked to regularly track withdrawal symptoms in diaries to help the study team monitor safety and response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older).
- You have kratom dependence and are currently in a kratom withdrawal period.
- You can understand and agree to participate, including consent for reviewing your symptom diaries and medical records.
- You can keep reliable daily diaries for withdrawal symptoms (both SOWS and COWS, as requested by the study).
- You have a history of taking part reliably (good treatment compliance).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two cannabis-like medicines, dronabinol and Epidiolex, can help reduce withdrawal symptoms and other discomforts people may feel when they first start taking buprenorphine for opioid use disorder. If you've recently started buprenorphine and still have symptoms, this study might offer extra relief.
This trial tests a physical device (ADTPM 1) to help manage withdrawal symptoms in people who are dependent on opioids. The goal is to see if the device can safely reduce withdrawal discomfort.
This trial tests how safe certain psychoactive substances are and what effects they have in people who have used opioids in the past but are not currently dependent on them. It aims to gather information that could help future treatment options.
This study watches how regular kratom users react to their own kratom product. It aims to learn more about kratom's effects in real-world settings.
This study compares different treatments for opioid dependence, specifically looking at a new way of giving buprenorphine (a medicine that reduces cravings) versus standard treatment. If you have opioid dependence, this trial might help find a more convenient and effective treatment option.
This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.
Hear when a new Withdrawal Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.